TT-816

· Teon Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TT-816, covering 2024-11-21 to 2024-11-21. Get the full timeline:

Most recent: Clinical Trial Update: TT-816 As Monotherapy or in Combination with a PD-1 Inhibitor in Patients with Advanced Cancers (SEABEAM) (MK3475-E88) [Phase 1, Phase 2]

See pricing